Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Microbiology|October 30, 2001
Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeastsY C Chen, J D Eisner, M M Kattar, et al.Journal of Clinical Microbiology|June 2, 2000
Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genesY C Chen, J D Eisner, M M Kattar, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 3, 2013
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipientD R Drozd, A P Limaye, R B Moss, et al.Transplantation Proceedings|February 7, 2018
Unintended Consequences in Use of Increased Risk Donor Kidneys in the New Kidney Allocation EraA A Rahnemai-Azar, J D Perkins, N Leca, et al.Clinical and Vaccine Immunology : CVI|October 26, 2007
Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipientsD C Saha, D L Goldman, X Shao, et al.Journal of Clinical Microbiology|February 3, 2000
Application of 16S rRNA gene sequencing to identify Bordetella hinzii as the causative agent of fatal septicemiaM M Kattar, J F Chavez, A P Limaye, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2010
The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipientsA Humar, Y Lebranchu, F Vincenti, et al.Epidemiology and Infection|January 10, 2017
Hospital-acquired listeriosis linked to a persistently contaminated milkshake machineE Mazengia, V Kawakami, K Rietberg, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 6, 2012
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trialD J Winston, F Saliba, E Blumberg, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2026
A Phase 2 Multi-Center, Prospective, Randomized, Double-Blind Study to Assess the Clinical and Antiviral Efficacy and Safety of Nitazoxanide for the Treatment of Norovirus in Hematopoietic Stem Cell and Solid Organ Transplant RecipientsCatherine-Audrey Boutin, M Callegari, D Florescu, et al.Pageof 4